In another cross-sectional baseline data analysis of the general asthma population, 78% of all patients had the characteristics of allergic asthma (potentially eligible for anti-IgE therapy), while it was indicated that 39.5% of them would also respond to antieosinophilic therapy (anti-IL-5(R) therapy). Here, IL5 is linked to asthma.